Related Experiment Video
Updated: Feb 11, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke
Xingyang Yi1, Jing Lin2, Yanfen Wang1
1Department of Neurology, People's Hospital of Deyang City, Deyang 618000, Sichuan, China.
Insights
Clopidogrel resistance (CR) is common in acute ischemic stroke (IS) patients and increases the risk of early neurological deterioration (END). Dual antiplatelet therapy with clopidogrel plus aspirin may help prevent END.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- The relationship between clopidogrel response and early neurological deterioration (END) after acute ischemic stroke (IS) requires further clarification.
- Understanding clopidogrel resistance (CR) is crucial for optimizing antiplatelet therapy in IS patients.
Purpose of the Study:
- To evaluate the association between clopidogrel resistance (CR) and early neurological deterioration (END) in acute ischemic stroke (IS) patients.
- To analyze the effectiveness of clopidogrel alone versus clopidogrel plus aspirin in preventing END.
Main Methods:
- Prospective, two-center study involving 375 IS patients treated with clopidogrel alone or in combination with aspirin.
- Platelet aggregation was measured using adenosine diphosphate (ADP)-induced aggregation to assess CR.
- Primary endpoint was END within 10 days; secondary endpoints included recurrent ischemic events and mortality.
Main Results:
- Clopidogrel resistance (CR) was observed in 40.8% of patients; 25.3% experienced END within 10 days.
- Higher platelet aggregation on admission and lower inhibition post-treatment were associated with END.
- Diabetes mellitus, CR, and dual antiplatelet therapy (clopidogrel plus aspirin) were independent predictors of END.
Conclusions:
- Clopidogrel resistance (CR) and early neurological deterioration (END) are frequent occurrences in acute ischemic stroke (IS).
- CR is significantly associated with an increased risk of END.
- Combination therapy with clopidogrel and aspirin demonstrates superior platelet aggregation inhibition and may offer protection against END.
Purpose:
The relationship between response to clopidogrel and early neurological deterioration (END) after acute ischemic stroke (IS) is not well defined. The aim of present study was to evaluate the associations of clopidogrel resistance (CR) with END, and stratified analyze the effectiveness of clopidogrel alone and clopidogrel plus aspirin for the prevention of END.
Results:
A total of 375 patients, 144 patients were received clopidogrel alone, 231 patients took clopidogrel plus aspirin. CR occurred in 153 patients (40.8%). 95 (25.3%) patients developed END within the first 10 days. Platelet aggregation was higher on admission, and inhibition of platelet aggregation was significantly lower in patients with END than patients without END. Diabetes mellitus, CR, and clopidogrel plus aspirin were independently associated with END. Dual antiplatelet therapy with aspirin and clopidogrel can inhibit both arachidonic acid (AA)-induced and ADP-induced platelet aggregation.
Methods:
This was a prospective, two-center study. A total of 375 IS patients taking clopidogrel alone or clopidogrel plus aspirin were enrolled. Platelet aggregation was measured before and after the 7-10 day treatment. CR was assessed by adenosine diphosphate (ADP)-induced platelet aggregation. The primary endpoint was END within the 10 days after admission. The secondary endpoint was a composite of recurrent ischemic stroke, myocardial infarction, and death during the 10 days after admission.
Conclusions:
CR and END are fairly common after acute IS. CR is associated with higher risk of END. Clopidogrel plus aspirin combination therapy provides greater inhibition of platelet aggregation, and may afford protection against END.
More Related Videos
Related Concept Videos
Mortar Joint Deterioration in Masonry
The...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

